Trinity Life Sciences

Climate Impact & Sustainability Data (2020-06 to 2023)

AstraZeneca partnered with My Green Lab to reduce environmental impact, including the lab’s Freezer Challenge, yielding over 1 million kWh/year in energy savings.
Companies are aiming to reduce nonrenewable components within their products, devices, and packaging.
Sanofi's EVolutive Facilities in France digitalized and “greened” vaccine and biological manufacturing, aiming for carbon neutrality.
Companies implemented a “SMASH Packaging” strategy, optimizing resources and using sustainable materials that maximize recycling potential.
Merck’s products generate fewer emissions than competitors due to less packaging & energy needs.
Philips’s EcoDesign initiative focuses on device energy efficiency, raw materials use, and recyclability.
Reductions in packaging size and weight have yielded fewer carbon emissions.
Allergan realized EUR 1.63 billion in savings in 2022 due to differences in cold chain handling and packaging needs compared to Merz's Xeomin®.

Long-term Goals:

Medium-term Goals:

Short-term Goals:

Pharma generates >50% more emissions per dollar of revenue than the automotive industry.
Pharma manufacturing is water-intensive and generates significant levels of wastewater.
Limited recyclability of pharmaceutical products, producing >100,000 tons of trash globally annually.
Sector emissions projected to grow by 3x by 2050 if unchecked.

Initiatives focusing on water use, raw materials sourcing, and waste generation across the R&D process, product manufacturing, and packaging/disposal decisions.
Targeted elimination of PVC in packaging by 2025 and plastic neutrality by 2030.
Commitments of 100% renewable energy sourced by 2030.

Frameworks Used:

Certifications: